Tech Company Financing Transactions

Code Biotherapeutics Funding Round

Northpond Ventures, 4BIO Capital and Amgen Ventures participated in a $75 million Series A funding round for Code Biotherapeutics. The round was announced on 6/7/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2801 Sterling Dr.
Hatfield, PA 19440
USA

Phone

Undisclosed

Website

www.codebiotx.com

Email Address

Not Recorded

Overview

Code Bio was founded on the belief that so much more can be done for people living with debilitating genetic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian McVeigh

        

Chief Technical Officer

Robert Getts

        

Vice President

Lori Getts

        

VP - Bus. Development

Lauren Kaskiel

        

Browse more venture capital transactions:

Prev: 6/7/2022: Geode Finance venture capital transaction
Next: 6/7/2022: Teal venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary